Abstract
A series of 1-arylpyrazole and their N- and S- glycosides has been synthesized. The key step is the synthesis of 3- (furan-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde 1 via Vilsmeier -Haack reaction on the hydrazone of 2-acetylfuran. Compound 1 was transformed to N,N-dialkyl acrylamide (and/or acetamide) derivatives 3a, 3b and 6 through reaction with malonic acid and application of Willgerodt-Kindler reaction followed by reaction with dialkylamine. Moreover, the aglycons 5-[3-(furan-2-yl)-1-phenyl-1H-pyrazol-4-yl]-1,3,4-oxadiazole-2(3H)-thione 10 and 6-(furan-2-yl)-4-[3-(furan-2- yl) -1-phenyl-1H-pyrazol-4-yl]-2-oxo -1,2-dihydro-pyridine-3-carbonitrile 14b were prepared and coupled with 2,3,4,6- tetra-O-acetyl-α-D-gluco pyranosyl bromide under basic conditions to yield S-and N-glycoside derivatives 12 and 15, respectively. All the newly synthesized compounds were confirmed by IR, 1H NMR, 13C NMR and mass spectral studies. Antiviral activity was shown for most of the synthesized compounds. Compounds 4 and 14b exhibited a promising antiviral activity against vesicular stomatitis virus (VSV).
Keywords: Antiviral Activity, Cytotoxicity, N-Nucleosides, Oxadiazoles, Pyrazoles, Thioglycosides, anticoagulant activity, S- Glycosides, 1H NMR, N- Glycosides, t vesicular stomatitis virus (VSV)., β-substituted acrylic acid, N, N- dimethylacetamide derivative, Acetamide, Esterification, hydrazinolysis
Letters in Drug Design & Discovery
Title: Synthesis and In Vitro Antiviral Evaluation of Novel 1-Arylpyrazoles and Their N- and S-Glycosides
Volume: 8 Issue: 9
Author(s): Emad M. El-Telbani, Sara M. Ghanem, Farrag A. El-Essawy and Aly F. El-Sayed
Affiliation:
Keywords: Antiviral Activity, Cytotoxicity, N-Nucleosides, Oxadiazoles, Pyrazoles, Thioglycosides, anticoagulant activity, S- Glycosides, 1H NMR, N- Glycosides, t vesicular stomatitis virus (VSV)., β-substituted acrylic acid, N, N- dimethylacetamide derivative, Acetamide, Esterification, hydrazinolysis
Abstract: A series of 1-arylpyrazole and their N- and S- glycosides has been synthesized. The key step is the synthesis of 3- (furan-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde 1 via Vilsmeier -Haack reaction on the hydrazone of 2-acetylfuran. Compound 1 was transformed to N,N-dialkyl acrylamide (and/or acetamide) derivatives 3a, 3b and 6 through reaction with malonic acid and application of Willgerodt-Kindler reaction followed by reaction with dialkylamine. Moreover, the aglycons 5-[3-(furan-2-yl)-1-phenyl-1H-pyrazol-4-yl]-1,3,4-oxadiazole-2(3H)-thione 10 and 6-(furan-2-yl)-4-[3-(furan-2- yl) -1-phenyl-1H-pyrazol-4-yl]-2-oxo -1,2-dihydro-pyridine-3-carbonitrile 14b were prepared and coupled with 2,3,4,6- tetra-O-acetyl-α-D-gluco pyranosyl bromide under basic conditions to yield S-and N-glycoside derivatives 12 and 15, respectively. All the newly synthesized compounds were confirmed by IR, 1H NMR, 13C NMR and mass spectral studies. Antiviral activity was shown for most of the synthesized compounds. Compounds 4 and 14b exhibited a promising antiviral activity against vesicular stomatitis virus (VSV).
Export Options
About this article
Cite this article as:
M. El-Telbani Emad, M. Ghanem Sara, A. El-Essawy Farrag and F. El-Sayed Aly, Synthesis and In Vitro Antiviral Evaluation of Novel 1-Arylpyrazoles and Their N- and S-Glycosides, Letters in Drug Design & Discovery 2011; 8(9) . https://dx.doi.org/10.2174/1570180811108090822
DOI https://dx.doi.org/10.2174/1570180811108090822 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Activity of Drugs and Components of Natural Origin in the Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)
Central Nervous System Agents in Medicinal Chemistry Inhibitors of Secretory Phospholipase A2 Group IIA
Current Medicinal Chemistry Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke
Current Neurovascular Research Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews Anti-Infective Effects of Lactobacilli in the Gastrointestinal Tract
Current Medicinal Chemistry - Anti-Infective Agents Simvastatin is Protective During Staphylococcus aureus Pneumonia
Current Pharmaceutical Biotechnology Statins and Ischaemia Reperfusion Injury: A Molecular Biological Review
Current Vascular Pharmacology Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations
Current Drug Metabolism Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor
Current Medicinal Chemistry Induction of a Robust Humoral Response using HIV-1 VLP<sup>MPER-V3</sup> as a Novel Candidate Vaccine in BALB/c Mice
Current HIV Research Role of Nitric Oxide in Physiology and Pathology of the Gastrointestinal Tract
Mini-Reviews in Medicinal Chemistry Immunological Approaches for HIV Therapy
Current Drug Targets - Infectious Disorders Pharmacokinetic Properties of Rituximab
Reviews on Recent Clinical Trials Evaluation of Skin Permeability of Resveratrol Loaded Liposomes and Nanostructured Lipid Carriers using a Skin Mimic Artificial Membrane (skin-PAMPA)
Drug Delivery Letters Therapeutic Benefit and Biological Importance of Ginkgetin in the Medicine: Medicinal Importance, Pharmacological Activities and Analytical Aspects
Current Bioactive Compounds Leptin Signaling: A Key Pathway in Immune Responses
Current Signal Transduction Therapy The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Current Psychopharmacology Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
Current Pharmaceutical Design